| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/14/2011 | US20110086023 Combination antihistamine medication |
| 04/14/2011 | US20110086022 Methods for diagnosing and treating neuroendocrine cancer |
| 04/14/2011 | US20110086021 Sclerostin and the inhibition of WNT signaling and bone formation |
| 04/14/2011 | US20110086020 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases |
| 04/14/2011 | US20110086019 Polypeptides, antibody variable domains and antagonistsmethods for |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/14/2011 | US20110086004 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/14/2011 | US20110085981 Glycan-based drugs, therapies and biomarkers |
| 04/14/2011 | US20110085973 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
| 04/14/2011 | US20110085970 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 04/14/2011 | US20110085968 Articles comprising nano-materials for geometry-guided stem cell differentiation and enhanced bone growth |
| 04/14/2011 | DE102009045006A1 Anti-CD33 Antikörper und ihre Anwendung zum Immunotargeting bei der Behandlung von CD33-assoziierten Erkrankungen Anti-CD33 antibodies and their use for Immunotargeting in the treatment of CD33-associated diseases |
| 04/14/2011 | CA2813494A1 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences |
| 04/14/2011 | CA2777222A1 Il-17 family cytokine compositions and uses |
| 04/14/2011 | CA2776922A1 Vaccines comprising heat-sensitive transgenes |
| 04/14/2011 | CA2775997A1 Staphylococcus aureus divi1b for use as vaccine |
| 04/14/2011 | CA2775793A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | CA2775573A1 Generation, characterization and uses thereof of anti-her 3 antibodies |
| 04/14/2011 | CA2775564A1 Immunopotentiator-linked oligomeric influenza immunogenic compositions |
| 04/14/2011 | CA2774963A1 Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
| 04/14/2011 | CA2774953A1 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
| 04/14/2011 | CA2774734A1 A cytolytic rtx-toxin from gallibacterium anatis |
| 04/14/2011 | CA2767924A1 Generation of a broad t-cell response in humans against hiv |
| 04/13/2011 | EP2309270A1 Antigenic peptides for the detection of chlamydia-related bacteria and tests of diagnosis |
| 04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
| 04/13/2011 | EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 04/13/2011 | EP2308985A2 Plastid genetic engineering via somatic embryogenesis |
| 04/13/2011 | EP2308981A1 Streptococcal C5a peptidase vaccine |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308898A1 Internalizing anti-CD74 antibodies and methods of use |
| 04/13/2011 | EP2308888A1 Anti-IL-6 antibodies, compositions, methods and uses |
| 04/13/2011 | EP2308507A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/13/2011 | EP2308506A1 Adjuvanted intranasal vaccine formulations |
| 04/13/2011 | EP2308505A2 Multiple vaccines including serogroup C meningococcus |
| 04/13/2011 | EP2308504A2 Multiple vaccines including serogroup C meningococcus |
| 04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
| 04/13/2011 | EP2307549A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 04/13/2011 | EP2307459A2 Notch1 receptor binding agents and methods of use thereof |
| 04/13/2011 | EP2307458A2 Humanization of rabbit antibodies using a universal antibody framework |
| 04/13/2011 | EP2307457A2 Stable and soluble antibodies inhibiting tnf |
| 04/13/2011 | EP2307456A2 Ang-2 inhibition to treat multiple sclerosis |
| 04/13/2011 | EP2307454A2 Stable and soluble antibodies inhibiting vegf |
| 04/13/2011 | EP2307452A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 04/13/2011 | EP2307052A2 Anti-beta-2-microglobulin agents and the use thereof |
| 04/13/2011 | EP2307051A2 Notch-binding agents and antagonists and methods of use thereof |
| 04/13/2011 | EP2307050A1 Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human pd-1 antibody on cancers |
| 04/13/2011 | EP2307049A1 Non-hemolytic llo fusion proteins and methods of utilizing same |
| 04/13/2011 | EP2307048A2 Hiv vaccine based on targeting maximized gag and nef to dendritic cells |
| 04/13/2011 | EP2307047A2 Respiratory syncytial virus renders dendritic cells tolerogenic |
| 04/13/2011 | EP2307036A1 Novel peptide adjuvant for influenza vaccination |
| 04/13/2011 | EP2307033A2 Use of oncolytic herpes viruses for killing cancer stem cells |
| 04/13/2011 | EP1697033B1 Process for cryogranulation and storage of allergens |
| 04/13/2011 | EP1440086B1 Infectious salmon anaemia virus vaccine |
| 04/13/2011 | EP1412485B1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/13/2011 | EP0957941B1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 04/13/2011 | EP0889735B1 Immunological methods for the treatment of gastrointestinal cancer |
| 04/13/2011 | CN1909924B Mucosal vaccine adjuvants containing bacterial flegellins as an active component |
| 04/13/2011 | CN1763097B Polypeptide variants with altered effector function |
| 04/13/2011 | CN1759123B Uses of IL-23 agonists and antagonists, related reagents |
| 04/13/2011 | CN1649902B Internalizing anti-CD74 antibodies and methods of use |
| 04/13/2011 | CN1379820B Lentiviral vectors for preparation of immunotherapeutical compositions |
| 04/13/2011 | CN102016034A Bacterial toxin vaccine |
| 04/13/2011 | CN102015769A Improved anti-TRKB antibodies |
| 04/13/2011 | CN102015767A Cross-neutralizing human monoclonal antibodies to SARS-CoV and methods of use thereof |
| 04/13/2011 | CN102015766A Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| 04/13/2011 | CN102015755A Vaccines and vaccine components for inhibition of microbial cells |
| 04/13/2011 | CN102015754A Klebsiella antigens |
| 04/13/2011 | CN102014959A Modulation of blood brain barrier permeability |
| 04/13/2011 | CN102014958A Inhibitors of GM-CSF and IL-17 for therapy |
| 04/13/2011 | CN102014957A Auris formulations for treating otic diseases and conditions |
| 04/13/2011 | CN102014956A PSMA binding ligand-linker conjugates and methods for using |
| 04/13/2011 | CN102014955A Carbohydrate-containing pan cancer marker |
| 04/13/2011 | CN102014954A Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season |
| 04/13/2011 | CN102014953A Immunogenic influenza composition |
| 04/13/2011 | CN102014952A Vaccine compositions for the treatment of dengue fever and uses thereof |
| 04/13/2011 | CN102014913A Combination therapy with C-MET and EGFR antagonists |
| 04/13/2011 | CN102010876A Recombinant bacillus subtilis EV71-VP1 expression vector and preparation method and application thereof |
| 04/13/2011 | CN102010471A Interleukin-10 antibodies |
| 04/13/2011 | CN102010463A Consensus/ancestral immunogens |
| 04/13/2011 | CN102008735A Small molecular DNA vaccine and preparation method thereof |
| 04/13/2011 | CN102008721A HPV (human papillomavirus) peptide/DC (dendritic cell) mixed vaccine and preparation thereof |
| 04/13/2011 | CN102008720A Clostridium welchii disease resistant transgenic plant vaccine and preparation method thereof |
| 04/13/2011 | CN102008719A Immunomicrosphere for overcoming B cell immunological tolerance and application thereof |
| 04/13/2011 | CN101333246B Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof |
| 04/13/2011 | CN101291675B Novel anticancer concomitant drug |
| 04/13/2011 | CN101058609B Human antibody and expression thereof |
| 04/13/2011 | CN101014365B Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody |
| 04/12/2011 | US7923560 Delivery of immune response modifier compounds |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7923539 IL-21 antagonists |
| 04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923247 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | US7923209 Allergen peptide fragments and use thereof |
| 04/12/2011 | US7923029 Freeze dried particles; respiratory system disorders |
| 04/12/2011 | US7923023 Method and composition for delivery of medicants to animals |
| 04/12/2011 | US7923018 Vaccine |